BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15358026)

  • 21. The venous system is the main determinant of hypotension in patients with vasovagal syncope.
    Fucà G; Dinelli M; Suzzani P; Scarfò S; Tassinari F; Alboni P
    Europace; 2006 Oct; 8(10):839-45. PubMed ID: 16916860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tilt training increases the vasoconstrictor reserve in patients with neurally mediated syncope evoked by head-up tilt testing.
    Verheyden B; Ector H; Aubert AE; Reybrouck T
    Eur Heart J; 2008 Jun; 29(12):1523-30. PubMed ID: 18375398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
    Gielerak G; Kozłowski D; Dłuzniewska E; Roszczyk A; Cholewa M
    Kardiol Pol; 2003 Feb; 58(2):98-108. PubMed ID: 14504635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tilt test in elderly patients with syncope of unknown etiology: experience with pharmacological stimulation with nitroglycerin.
    Timóteo AT; Oliveira MM; Antunes E; Vieira AP; Feliciano J; Fiarresga AJ; Silva S; Coito S; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):945-53. PubMed ID: 16240681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of heart rate variability during the head-up tilt test in patients with vasovagal syncope].
    Mitro P; Rybár R
    Vnitr Lek; 2002 Apr; 48(4):314-9. PubMed ID: 12061181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of head-up tilt test for patients with suspected vasovagal syncope.
    Liu J; Fang P; Liu Y; Lu G; Li Z; Li X; Wang Y
    Europace; 2011 Apr; 13(4):576-80. PubMed ID: 21357590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response?
    Russo V; Papa AA; Ciardiello C; Rago A; Proietti R; Calabrò P; Russo MG; Nigro G
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):507-13. PubMed ID: 25684414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medical device Task Force Monitor in diagnostics of syncope by means of head-up tilt table testing].
    Siegelová J; Fiser B
    Vnitr Lek; 2006 Feb; 52(2):160-6. PubMed ID: 16623279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tilt-table-testing in childhood: non-invasive, continuous hemodynamic monitoring].
    DallaPozza R; Kleinmann A; Bechtold S; Netz H
    Klin Padiatr; 2007; 219(4):225-9. PubMed ID: 16878288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of clinical features with different hemodynamic patterns in head-up tilt test in children with unexplained syncope].
    Zhang QY; Du JB; Li WZ; Chen JJ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1962-5. PubMed ID: 16313771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate and blood pressure variability in subjects with vasovagal syncope.
    Piccirillo G; Naso C; Moisè A; Lionetti M; Nocco M; Di Carlo S; De Laurentis T; Magrì D; Cacciafesta M; Marigliano V
    Clin Sci (Lond); 2004 Jul; 107(1):55-61. PubMed ID: 14982493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late hemodynamic changes during a negative passive head-up tilt predict the symptomatic outcome to a nitroglycerin sensitized tilt.
    Bellard E; Fortrat JO; Schang D; Dupuis JM; Victor J; Lefthériotis G
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):89-96. PubMed ID: 15679637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent vasovagal syncope: comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing.
    Flevari P; Leftheriotis D; Komborozos C; Fountoulaki K; Dagres N; Theodorakis G; Kremastinos D
    Eur Heart J; 2009 Sep; 30(18):2249-53. PubMed ID: 19556259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carotid baroreflex function ceases during vasovagal syncope.
    Ogoh S; Volianitis S; Raven PB; Secher NH
    Clin Auton Res; 2004 Feb; 14(1):30-3. PubMed ID: 15045598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do subjects with vasovagal syncope have subtle haemodynamic alterations during orthostatic stress?
    Fucà G; Dinelli M; Gianfranchi L; Bressan S; Lamborghini C; Alboni P
    Europace; 2008 Jun; 10(6):751-9. PubMed ID: 18375967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
    Aslan O; Guneri S; Badak O; Kirimli O; Goldeli O; Keskin V; Akdeniz B; Tekin U
    Can J Cardiol; 2002 Aug; 18(8):853-9. PubMed ID: 12215748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between results of head-up tilt test and clinical features in patients with syncope or presyncope.
    Emkanjoo Z; Alizadeh A; Alasti M; Fadaie AA; Haghjoo M; Fazelifar AF; Sadr-Ameli MA
    J Electrocardiol; 2007 Apr; 40(2):200-2. PubMed ID: 16963069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with unexplained syncope.
    Kirsch P; Mitro P; Mudrakova K; Valocik G
    Bratisl Lek Listy; 2007; 108(6):259-64. PubMed ID: 17972537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of nitroglycerin in the active phase of tilt testing: is there a difference in elderly patients?
    Timóteo AT; Oliveira M; Antunes E; Pelicano N; Feliciano J; Silva S; Ferreira R; Quininha J
    Rev Port Cardiol; 2007 Apr; 26(4):321-30. PubMed ID: 17695728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head-up tilt table testing in syncope: safety and efficiency of isosorbide versus isoproterenol in pediatric population.
    Swissa M; Epstein M; Paz O; Shimoni S; Caspi A
    Am Heart J; 2008 Sep; 156(3):477-82. PubMed ID: 18760129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.